Khiron OTC Stock Valuation

KHRNF -  USA Stock  

USD 0.22  0.01  4.35%

What is the value of Khiron Life today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Khiron Life, is its stock price multiplied by the total number of shares outstanding, calculating Khiron Life's enterprise value requires a different approach. It uses Khiron Life's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Khiron Life seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Khiron Life Sciences from analyzing the firm fundamentals such as Profit Margin of (226.70) %, current valuation of 32.66 M, and Return On Equity of (34.85) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend purchasing undervalued stocks and exiting overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

Search Valuation 

 
Refresh
Khiron Life Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Khiron Life's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Overvalued
Today
0.22
21st of September 2021
Share
Please note that Khiron Life's price fluctuation is out of control at this time. Calculation of the real value of Khiron Life Sciences is based on 3 months time horizon. Increasing Khiron Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Khiron Life Sciences is useful when determining the fair value of the Khiron otc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Khiron Life. Since Khiron Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Khiron OTC Stock. However, Khiron Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
0.21
Real Value
4.85
Upside
Estimating the potential upside or downside of Khiron Life Sciences helps investors to forecast how Khiron otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Khiron Life more accurately as focusing exclusively on Khiron Life's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.150.250.35
Details
Hype
Prediction
LowEstimated ValueHigh
0.010.234.87
Details
Naive
Forecast
LowNext ValueHigh
0.0048140.244.88
Details

Khiron Life Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Khiron Life's current stock value. Our valuation model uses many indicators to compare Khiron Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Khiron Life competition to find correlations between indicators driving Khiron Life's intrinsic value. More Info.
Khiron Life Sciences is currently regarded as number one stock in beta category among related companies. It is rated second overall in price to book category among related companies fabricating about  0.31  of Price to Book per Beta. The ratio of Beta to Price to Book for Khiron Life Sciences is roughly  3.24 

About Khiron Life Valuation

The equity valuation mechanism determines the current worth of Khiron Life Sciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Khiron Life Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Khiron Life Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Khiron Life's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Khiron Life's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Khiron Life. We calculate exposure to Khiron Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Khiron Life's related companies.
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America, North America, and Europe. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands develops CBD-based cosmeceutical products under the Kuida brand name and operates Zerenia clinic in Medellin and Peru. Khiron Life is traded on OTC Exchange in the United States.

Khiron Life Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Khiron Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.08
Revenue Growth49.20%
Enterprise Value To Ebitda-1.69
Enterprise Value To Revenue3.65
Please see Stocks Correlation. Note that the Khiron Life Sciences information on this page should be used as a complementary analysis to other Khiron Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for activelly traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Khiron OTC Stock analysis

When running Khiron Life Sciences price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
The market value of Khiron Life Sciences is measured differently than its book value, which is the value of Khiron that is recorded on the company's balance sheet. Investors also form their own opinion of Khiron Life's value that differs from its market value or its book value, called intrinsic value, which is Khiron Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Khiron Life's market value can be influenced by many factors that don't directly affect Khiron Life Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Khiron Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Khiron Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Khiron Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.